| Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome YJ Cho, A Tsherniak, P Tamayo, S Santagata, A Ligon, H Greulich, ... Journal of Clinical Oncology 29 (11), 1424, 2011 | 561 | 2011 |
| β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis J Rosenbluh, D Nijhawan, AG Cox, X Li, JT Neal, EJ Schafer, TI Zack, ... Cell 151 (7), 1457-1473, 2012 | 475 | 2012 |
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma RGW Verhaak, P Tamayo, JY Yang, D Hubbard, H Zhang, CJ Creighton, ... The Journal of clinical investigation 123 (1), 2012 | 377 | 2012 |
| Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer HW Cheung, GS Cowley, BA Weir, JS Boehm, S Rusin, JA Scott, A East, ... Proceedings of the National Academy of Sciences 108 (30), 12372-12377, 2011 | 351 | 2011 |
| Defining a cancer dependency map A Tsherniak, F Vazquez, PG Montgomery, BA Weir, G Kryukov, ... Cell 170 (3), 564-576. e16, 2017 | 307 | 2017 |
| Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting AJ Aguirre, RM Meyers, BA Weir, F Vazquez, CZ Zhang, U Ben-David, ... Cancer discovery 6 (8), 914-929, 2016 | 273 | 2016 |
| Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies GS Cowley, BA Weir, F Vazquez, P Tamayo, JA Scott, S Rusin, ... Scientific data 1, 140035, 2014 | 244 | 2014 |
| Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells RM Meyers, JG Bryan, JM McFarland, BA Weir, AE Sizemore, H Xu, ... Nature genetics 49 (12), 1779, 2017 | 231 | 2017 |
| SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2 KH Kim, W Kim, TP Howard, F Vazquez, A Tsherniak, JN Wu, W Wang, ... Nature medicine 21 (12), 1491, 2015 | 178 | 2015 |
| Cancer vulnerabilities unveiled by genomic loss D Nijhawan, TI Zack, Y Ren, MR Strickland, R Lamothe, SE Schumacher, ... Cell 150 (4), 842-854, 2012 | 159 | 2012 |
| MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells GV Kryukov, FH Wilson, JR Ruth, J Paulk, A Tsherniak, SE Marlow, ... Science 351 (6278), 1214-1218, 2016 | 151 | 2016 |
| Genetic and transcriptional evolution alters cancer cell line drug response U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ... Nature 560 (7718), 325, 2018 | 130 | 2018 |
| ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screens DD Shao, A Tsherniak, S Gopal, BA Weir, P Tamayo, N Stransky, ... Genome research 23 (4), 665-678, 2013 | 108 | 2013 |
| SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer L Li, C Shen, E Nakamura, K Ando, S Signoretti, R Beroukhim, GS Cowley, ... Cancer cell 24 (6), 738-750, 2013 | 94 | 2013 |
| High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines C Yu, AM Mannan, GM Yvone, KN Ross, YL Zhang, MA Marton, BR Taylor, ... Nature biotechnology 34 (4), 419, 2016 | 65 | 2016 |
| Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features P Tamayo, YJ Cho, A Tsherniak, H Greulich, L Ambrogio, ... Journal of clinical oncology 29 (11), 1415, 2011 | 59 | 2011 |
| Next-generation characterization of the Cancer Cell Line Encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503, 2019 | 57 | 2019 |
| Characterizing genomic alterations in cancer by complementary functional associations JW Kim, OB Botvinnik, O Abudayyeh, C Birger, J Rosenbluh, Y Shrestha, ... Nature biotechnology 34 (5), 539, 2016 | 55 | 2016 |
| Analyzing system logs: A new view of what’s important S Sabato, E Yom-Tov, A Tsherniak, S Rosset Proceedings of the 2nd USENIX workshop on Tackling computer systems problems …, 2007 | 44 | 2007 |
| Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma AL Kennedy, M Vallurupalli, L Chen, B Crompton, G Cowley, F Vazquez, ... Oncotarget 6 (30), 30178, 2015 | 37 | 2015 |
David RootVerified email at broadinstitute.org
